# Successful anesthesia management for middle cerebral artery thrombectomy in a patient with asynchronous cardio-cerebral infarction: a case report

**Authors:** Lin Zhang, Zhuang Liu, Tingting Wu, Shoushi Wang, Tingting Song

PMC · DOI: 10.3389/fphar.2026.1711037 · Frontiers in Pharmacology · 2026-02-24

## TL;DR

A patient with heart and brain infarction successfully underwent brain artery thrombectomy with a tailored anesthesia plan.

## Contribution

This case report presents a novel anesthesia approach for high-risk cardio-cerebral infarction patients during thrombectomy.

## Key findings

- Non-intubated general anesthesia maintained hemodynamic stability during thrombectomy in a CCI patient.
- Combining sedation with tirofiban minimized ischemic and hemorrhagic risks without major complications.
- Immediate echocardiography helped identify cardiac dysfunction and thrombus source in this CCI case.

## Abstract

Cardio-cerebral infarction (CCI) is a rare syndrome characterized by acute ischemic stroke (AIS) occurring shortly after acute myocardial infarction (AMI). Currently, there are no evidence-based guidelines for perioperative anesthesia management in patients with CCI.

A 58-year-old male underwent coronary stent implantation for acute myocardial infarction (AMI) 4 days prior and was admitted for emergency mechanical thrombectomy due to occlusion of the right middle cerebral artery. Preoperative transthoracic echocardiography revealed left ventricular systolic dysfunction (ejection fraction <40%), segmental wall motion abnormalities, and a left ventricular apical thrombus, this case extends beyond simple post-myocardial infarction thromboembolism because the patient’s AIS occurred in the specific context of acute, severe cardiac dysfunction (EF <40%) with a documented left ventricular thrombus—a direct embolic source stemming from the recent AMI. This fulfills the criteria for “asynchronous cardio-cerebral infarction”, where the brain insult is a direct consequence of the cardiac event within a short temporal window. Anesthesia was managed using a non-intubated general anesthesia approach, involving titration of sedation with sufentanil and remifentanil, combined with norepinephrine to maintain mean arterial pressure (MAP) within ±20% of baseline. The risk of ischemia and hemorrhage was balanced with restrictive fluid management and continuous infusion of tirofiban. Intraprocedural hemodynamics remained stable, and the procedure was successfully completed. The patient was transferred to the general ward on postoperative day three and discharged on day eleven. Troponin I and brain natriuretic peptide (BNP) levels showed a downward trend, with no evidence of heart failure, hemorrhagic transformation, or acute kidney injury.

In this case of CCI patients, immediate echocardiography was helpful in quickly assessing cardiac function and determining the source of the thrombus. Non-invasive general anesthesia was beneficial in maintaining hemodynamic stability and airway safety. The multidisciplinary individualized anesthesia plan developed in this challenging scenario may provide practical references for perioperative management of similar high-risk CCI patients, but its general applicability still needs to be verified in larger-scale studies.

## Linked entities

- **Chemicals:** sufentanil (PubChem CID 41693), remifentanil (PubChem CID 60815), norepinephrine (PubChem CID 951), tirofiban (PubChem CID 60947), brain natriuretic peptide (PubChem CID 139211146)
- **Diseases:** acute myocardial infarction (MONDO:0004781), heart failure (MONDO:0005252), acute kidney injury (MONDO:0002492)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** NPPB (natriuretic peptide B) [NCBI Gene 4879] {aka BNP, Iso-ANP}
- **Diseases:** motion (MESH:D009041), apical (MESH:D010485), AIS (MESH:D000083242), ischemia (MESH:D007511), acute kidney injury (MESH:D058186), hemorrhage (MESH:D006470), left ventricular systolic dysfunction (MESH:D018487), CCI (MESH:D002544), AMI (MESH:D009203), occlusion of the right middle cerebral artery (MESH:D020244), brain insult (MESH:D001927), left ventricular thrombus (MESH:D013927), cardiac dysfunction (MESH:D006331), thromboembolism (MESH:D013923), heart failure (MESH:D006333), embolic (MESH:D004617)
- **Chemicals:** remifentanil (MESH:D000077208), norepinephrine (MESH:D009638), sufentanil (MESH:D017409), tirofiban (MESH:D000077466)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12971402/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12971402/full.md

## References

22 references — full list in the complete paper: https://tomesphere.com/paper/PMC12971402/full.md

---
Source: https://tomesphere.com/paper/PMC12971402